Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.

Aggressively treating blood pressure, cholesterol levels fails to improve cognitive function
Targeting key cardiovascular risk factors for two full years was not linked to a reduced risk of cognitive decline or dementia.
Early use of tirzepatide after heart attack or stroke linked to key cardiovascular benefits
When patients without diabetes land in the hospital after a heart attack or stroke, early treatment with tirzepatide may prove beneficial.
Another win for Wegovy: FDA approves higher semaglutide dose as part of new pilot program
Novo Nordisk will be selling the new 7.2-mg dose under the brand name Wegovy HD. The FDA's decision fell under a new pilot program intended to grant certain companies improved access and quicker approvals.
FDA clears MiniMed’s screenless, smartphone-controlled insulin pump
Just weeks after separating from Medtronic and going public, MiniMed secured FDA clearance for its next-generation insulin pump technology.
Morning exercise may have added benefits for the heart
With exercise, does timing really matter? According to one new study, working out early in the day was linked to a lower risk of heart disease and healthier blood pressure levels than working out at any other point in the day.

Aggressively treating blood pressure, cholesterol levels fails to improve cognitive function

Targeting key cardiovascular risk factors for two full years was not linked to a reduced risk of cognitive decline or dementia.

artificial intelligence AI in healthcare

Early use of tirzepatide after heart attack or stroke linked to key cardiovascular benefits

When patients without diabetes land in the hospital after a heart attack or stroke, early treatment with tirzepatide may prove beneficial.

overweight patient seeking health advice

Another win for Wegovy: FDA approves higher semaglutide dose as part of new pilot program

Novo Nordisk will be selling the new 7.2-mg dose under the brand name Wegovy HD. The FDA's decision fell under a new pilot program intended to grant certain companies improved access and quicker approvals.

FDA clears MiniMed’s screenless, smartphone-controlled insulin pump

Just weeks after separating from Medtronic and going public, MiniMed secured FDA clearance for its next-generation insulin pump technology.

Morning exercise may have added benefits for the heart

With exercise, does timing really matter? According to one new study, working out early in the day was linked to a lower risk of heart disease and healthier blood pressure levels than working out at any other point in the day.

Ultra-processed foods significantly increase a person’s risk of heart attack or stroke

Study participants who ate high amounts of ultra-processed foods were 66.8% more likely to experience a heart attack, stroke or cardiac arrest than those who did not.

doctor with overweight patient who may be treated with TAVR or surgery

New obesity statistics highlight importance of preventive cardiology

Cardiovascular health is much worse in some parts of the United States than others. Cardiologists in those high-risk areas can make a world of difference by embracing preventive cardiology and working to treat patients before it is too late.

Insulet Corporation has announced a voluntary recall for specific lots of the pods associated with its Omnipod 5 Automated Insulin Delivery System

FDA announces recall of insulin delivery pods

Small tears were found on the inside of some of Insulet Corporation's Omnipod 5 pods. The issue was linked to a total of 18 serious adverse events.